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Executive Summary 
 
 
 
Eskayef Bangladesh Limited is the country‟s one of the leading pharmaceutical company with a 
controlling blend of skills and resources to offer a stage for bringing strong growth in today‟s 
quickly altering health care environment.  
 
Lately there has already been much anticipation over the development of bringing pellets in the 
market.  For the first time, in the market SK+F is bringing vitamin C supplement ascorbic acid in 
the form of juice called - “JUCI”.  
 
The formerly Vitamin C supplement in juice form in Bangladesh. “JUCI” is a healthy juice 
which will be on the market in Sachets. Everyday our body needs immense amount of Vitamin C 
to keep us healthy by enabling our tissue growth, controlling our blood pressure, and also 
providing great help to the adrenal gland and to the coenzymes. It also makes our skin and hair 
healthy.   
 
Here I have focused on how we will differentiate our product from the competitors to get a big 
exposure in the eyes of the consumers. I have put some light on how the target market will be 
analyzed and how to put impact on the growth of that specific market.  
 
I have also focused on the promotional activities where generating consciousness among the 
people gets urgency.  Various vehicle will be used for this promotional activities where we will 
provide samples and place “reactive magnet agent” in different institutions of the society.  
 
I have finished with some recommendations which I think, will be helpful for SK+F to 
understand their gaps and how they can reach the aimed position.  
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Introduction 
Eskayef Bangladesh Ltd (SK+F) is known as one of the top pharmaceutical company in 
Bangladesh. It is a part of the TranscomGroup, a fully owned subsidiary of Transcom Limited. 
From the start, the company was very much successful in generating increased demand for its 
products which ultimately justified local production. With capable, educated, and skilled 
professionals on its personnel and its concrete standards of quality control, the company has 
distinguished itself as one of the most respected names in the pharmaceutical industry. SK+F‟s 
manufacturing facility has transcended the frontiers after the accreditation of UK MHRA (United 
Kingdom Medicines and Healthcare products Regulatory Agency), TGA Australia and UMD 
UK. 
 
Background 
EskayefBanglaedesh Limited (formerly Smith & Kline & French Bangladesh Limited) is a 
Bangladeshi Private company by shares engaged in manufacturing and marketing of 
pharmaceutical products since October 30, 1990. Originally Smith Kline & French was 
incorporated in June 12, 1979 as limited company in Bangladesh. In April 1990 the shares were 
purchased by Bangladeshi shareholders and the business operation continued uninterrupted under 
the new name ESKAYEF BANGLADESH LIMITED. The registered office of the company is in 
Dhaka.The company is 99.99% owned subsidiary of Transcom Limited. 
Eskayef Pharmaceuticals manufacturing facilities are spread across a 20-acre site situated in 
Dhaka, Bangladesh. The facilities encompass of a number of purpose-built plants, including an 
Oral Solid Dosage (OSD) plant. The site includes manufacturing facilities as well as a research 
laboratory and a number of warehouses. The plant and machinery of the facilities were procured 
and installed from Germany, Switzerland, Sweden, Italy, United Kingdom (UK) and other 
countries. 
It is growing more global since 2005, exporting bulk pellets, and finished products in Asia, 
Africa, and Central America and also in the development of exporting in the European countries. 
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The company is also attached with the Allergan Inc., one of the world leaders in eye care 
solution. Current growth rate of Eskayef is 18 percent and ranked 6th among the local 
companies. 
 
 
Mission Statement 
Eskayef envisions a leading role for itself as a catalyst for improvement of the healthcare 
environment. The company's mission is to Maintain people's health and combat disease to 
enhance the quality of human life so that people may live longer, healthier and more 
meaningful lives. 
 
 
Vision Statement 
If there is one characteristic that has typified the Eskayef approach is the vision to be the best of 
its natural & human resources. The vision of Eskayef is to Establish our group & country as 
respected & valued regional presence. 
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Milestones 
 
Year 
 
Milestones 
1985 SK&F started its operation in Bangladesh. 
1990 Acquisition by Transcom Company Limited from Smith Kline & French. 
1990 Re-branded to Eskayef Bangladesh Limited (SK+F) from SK&F. 
2001 Eskayef added Agro vet (animal health) Division in business. Also coming 
up with pellets for the first time in Bangladesh. 
2002 Eskayef became the authorized distributor of Allergan Inc., a global leader 
in eye care medicine,  in Bangladesh 
2004 Eskayef implemented ACCPAC ERP software. 
2006 Establishment of Tongi Plant. 
2007 IMS ranked as 4th largest pharmaceutical company in Bangladesh. 
2008 Tongi Plant has achieved the approval of United Kingdom Medicines and 
Healthcare products Regulatory Agency (UK MHRA), Department of 
Health, UK. 
2010 IMS ranked as 5th largest pharmaceutical company in Bangladesh. 
2010 Plant of Eskayef Bangladesh Limited at Tongi has achieved approval from 
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Corporate Info 
 
Company name : Eskayef Bangladesh Limited  
Company logo :  
Company slogan : Excellence through Quality 
Company type : Private limited company 
Owner :  Transcom Limited 
Acquisition from : SmithKline & French 
Acquisition In : 1990  
Initial Name : SK&F 
Re-Branded In :  1990 
Factories  : Mirpur (generic), Tongi (generic & cephalosporin), 
Rupgong plant (under construction). 
Marketing office : Taneem Square, Banani, Dhaka 
Commercial Dept. :  Taneem Square, Banani, Dhaka 
International Business    :  Taneem Square, Banani, Dhaka 
Finance & Accounts : Gulshan Tower, Gulshan 2, Dhaka 
AHND office : Tanim Square,Banani, Dhaka   
Annual Sales turnover : BDT 7357 million, US$ 94 million 
Web address : www.skfbd.com 
E-mail : info@skf.transcombd.com 
Employees  :  3390 (permanent); 4336 (around total) 
IMS ranking : 6th largest in Bangladesh Pharmaceuticals Industry. 
Prime brand : Losectil (Omeprazole), Xinc, Dexpoten. 
Therapeutic Goods Administration (TGA), Australia 
2010 Eskayef opens insulin plant with Novo Nordisk. 
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Business : Formulation, Consumer, Bulk Pellets, AHND 
Distributor : Transcom Distribution Company Limited, (TDCL). 
Depots    :  28 Depots Accountability. 
Regions : 33 Regions. 
 
Organizational Organogram 
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Description of the Job: 
 
I got the chance to do the internship in SK+F‟s regulatory division in the post under the 
supervision of the line manager. There are two division working under the supervision of the 
general manager. One is the accounting division, another the HR division.  
It was a great opportunity for me to work at both of the departments. In the first half of my 
internship I worked with the Accounts Payable section in Accounting department and the rest 
half in the HR department. In accounts payable department my work was mostly related with 
recording and calculating payable accounts of the company. In this time I got the chance to learn 
Sage Accpac ERP software. In the HR department I learned to use a customized leave 
calculating software called Softpen.  
 
Specific Responsibilities: 
 
1.In the accounts payable section I had to record the LC’s which comes from multiple bank statements. 
Later they are added in the Accpac software under respective GL head. 
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2.The second work I had to do was Reconciliation to determine that two sets of records (usually 
the balances of two accounts) are in agreement. Reconciliation is used to confirm that the 
moneyleaving an account matches the actual money spent. I used to do reconciliation of HSBC, 
Prime Bank, SCB Bank, Pubali Bank, CBCL Bank. 
 
 
3.Recording C&F bill by calculating the vats, taxes and expenses on customs and supply duty to 
generate the cost of each exports. All the data also goes in the Accpac under respective GL head. 
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4. Calculate the claim of the insurance of the damaged products on the portion of accidents 
involved according to the Deal. 
5. Right here are some previews from the Accpac software I used.  
 
 
 
12 | P a g e  
 
 
  
6.In HR department I had to calculate and record leaves of the managerial and non-managerial. 
 
Observations 
 
So far SK+F has a good reputation both inside and outside their corporate walls. The 
environment inside SK+F‟s regulatory division is really calm and in peace. Everybody is 
working inside their own cubicles quietly. There is no rush over here like the marketing 
department. Everything is going under a flow of data share and analysis. The works are very 
smartly divided into the managers and the officers. The key here is co-ordination. Inside the 
environment no politics are appreciated. Everyone works with harmony. Everyone maintaining a 
perfect routine to come to the office but many are staying for nights to work more. There is lack 
of room for any kind of fault. As papers are still used in the office for data collecting, more 
office space might be needed someday soon. 
 
 
Recommendations 
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My recommendation for SK+F‟s regulatory division is that, 
New systems could be applied to emphasize on collecting the information from the source, 
especially in accounts receivable dept. It will make the work become faster and less papers will 
be misused. 
 
 
 
 
 
 
Project Summary 
One of the essential requirements of the body are vitamins, a class of nutrients that are necessary 
for its various biochemical and physiological processes. However, the human body usually does 
not synthesize them; therefore, they must be provided by the diet in the mandatory amount. 
Vitamins are sectioned into fat-soluble and water soluble vitamins. Fat-soluble vitamins are 
soluble in fat solvents. They are A, D, E and K. Water-soluble vitamins are soluble in water and 
include vitamin C and vitamin B series that are usually labeled as vitamin B complex.  
Vitamin C (Ascorbic Acid) is a water-soluble antioxidant. It was initially isolated in 1928, by the 
Hungarian biochemist and Nobel Prize winner Szent-GyorGyi. It is unsteady and simply 
oxidized acid that can be damaged by oxygen with high temperature.  
Humans cannot synthesize vitamin C contrasting animals, rendering its absorption from 
exogenous supplement or diet necessary. It has been projected that the reason of human 
incapability to synthesize ascorbic acid is the deficiency of the active enzyme, l-gulonolactone 
oxidize from the liver (Burns, 1959). For standard physiological functions body have need of 
vitamin C. It services in the metabolism of tyrosine, folic acid and tryptophan. It lowers blood 
cholesterol and contributes to the synthesis of the amino acids carnitine and catecholamine 
(Included are: epinephrine(adrenaline), norepinephrine(noradrenaline) and dopamine) that 
regulate nervous system. It is necessity for tissue growth and wound healing. It acts as a support 
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in the formation of neurotransmitters and upturns the absorption of iron in the gut. As it is an 
antioxidant, it safeguards the body from the detrimental effects of free radicals and pollutants. 
Massive doses of vitamin C is used in the treatment and avoidance of large number of disorders 
like diabetes, cataracts, glaucoma, macular degeneration, atherosclerosis, stroke, heart diseases 
and cancer. 
Absence of this vitamin can lead to anemia, scurvy, infections, bleeding gums, muscle 
degeneration, poor wound healing, atherosclerotic plaques, capillary hemorrhaging and neurotic 
disturbances. Toxicity ordinarily does not occur. 
Infections reduce the body stores of vitamin C, thus making the body immune system fragile. To 
have a durable immunity, body requires vitamin C. Optimal tissue stores uphold resistance to 
infections. Vitamin C therapy is valuable in the treatment of different infections and infectious 
diseases, for example hepatitis, HIV, H. pylori infection, common cold, flu and influenza etc. 
Ascorbic acid, the recognized name for vitamin C, is obtainable in reduced form (L-ascorbic 
acid) and oxidized form (Ldehydroascorbic acid). It is originated in citrus fruits, green peppers, 
red peppers, strawberries, tomatoes, broccoli, brussels sprouts, turnip and other leafy vegetables. 
Fish and milk also contain small amounts of vitamin C.  
 
Description of Project 
 
Eskayef Bangladesh Ltd. will soon be coming up with a Vitamin C supplement called “Juci”. I 
worked with the marketing department of SK+F to develop a business plan for Juci so that it can 
penetrate the market and become one of the few names that come up in the consumers mind 
when they think of Vitamin C supplements. 
Objective 
 
The objective of this project is: 
 To create a marketing plan for Juci. 
 To make Juci the market leader as a generic Ascorbic Acid supplement. 
 To create an image in consumers‟ mind considering the product category 
 To find an essential way to communicate with the target markets 
Methodology 
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The report has been prepared on the basis of secondary data collected from publications, and 
internet. The collected data were analyzed and consolidated. The data analysis procedure 
endorsed by the company, such as SWOT Analysis has been used to analyze data for the report. 
By selecting few target market the USP for Juci was also developed during the inception of the 
project. Markets were analyzed in regards to Philip Kotler‟s 4 Principles of Marketing and 
different ATL and BTL strategies were developed to ensure proper product communication. 
Limitations 
 
As previously stated I got the chance to do the internship on the Finance, Accounting and HR 
division of SK+F. So, I had a limited time frame to go through every aspects of the Marketing 
department. For this reason, many of the bookish way of analyzing were compromised and not 
elaborated on the highest order. Still few of the techniques were undertaken, where the 
concentration was improvised mostly regarding the consumers.  
 
 
 
 
 
 
 
LAUNCH PLANNING 
 
PRODUCT OVERVIEW 
 
To live a happy life our body should have a good immune system and be full with energy. The 
Citrus fruits and vegetables we take enrich our immune system, helps with tissue growth. 
However, on the current condition in Bangladesh where corruption is spread like a spider web, it 
is really hard to get fruits and vegetables without preservatives in it. On the other hand our seven 
major glands in the body mostly get empowered by fruits and vegetables. Citrus fruits are one 
kind of fruit that provides ascorbic acid and helps few of the seven glands. Adrenal gland being 
one of the major glands needs ascorbic acid to function properly. Adrenal gland (divided into 
two regions: adrenal medulla and adrenal cortex) helps increase rate in blood circulation, 
preparing muscles for exertion and create carbohydrate metabolism. Nevertheless only citrus 
fruits cannot provide enough ascorbic acid needed and it cannot be produced by the body itself. 
 
So, SK+F is coming up with a new product in the market called “JUCI” ascorbic acid USP 
500mg Sachet. “Juci” comes in the color of green symbolizing nature to its every drop. It comes 
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in the flavor of orange. Every sachet of “Juci” will cost 10 taka where a packet will contain 20 
sachet means 200 taka per packet. 
 
“Juci” will provide ascorbic acid and will help with developing the antioxidant which protects 
against harmful pollution, infection and reduce cellular damage. It also increases the activities of 
the coenzyme which will help in wound healing, metabolism of dopamine (Neurotransmitter), 
cholesterol and folic acid. 
 
Generally 
 
1. Helps tissue growth repair 
2. Adrenal gland function 
3. Enhanced immunity & 
4. Healthy gums. 
 
Defined Indications 
 
1. Healthy capillaries, gums & teeth. 
2. Aids in iron absorption. 
3. Helps in healing wounds & broken bones. 
4. Prevents & treats scurvy 
5. Helps to treat anemia, especially iron deficiency anemia by increasing absorption of iron 
from the intestines.  
6. Helps to form collagen in connective tissues. 
7. Production of hemoglobin & red blood cell in bone marrow. 
8. Aids in preventing many types of viral and bacterial infections and potentiates the 
immune system. 
9. Aids in the treatment of prevention of the common cold. 
Nutrient 
 
1. Protection against blood clotting  
2. Ensures healthy hair & skin. 
Disadvantage 
 
Any excess amount of vitamin C that is consumed will be excreted through a constant turnover 
process. 
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Contradiction 
 
Patients with a known hypersensitivity to vitamin C or any of its ingredients will not be preferred 
to take the product. 
Warnings 
 
Avoid taking vitamin C supplements in case of a history of kidney stones or kidney disease. 
 
 
 
 
 
 
 
 
 
MY PROPOSAL ON PRE-LAUNCH ACTIVITIES 
 
Marketing Strategy: 
As a matter of synopsis we will look at the structure of the market strategy below to get a bird‟s 
eye view to understand the market regarding the consumer‟s decision.   
 
Market Analysis Market 
Segmentation 
Market Strategy Consumer decision 
process 
Company:  
SK+F. 
Identified product 
related needs and 
group of customers 
with similar needs: 
Group 1. 
Product: 
1. ‘Juci” works as a 
supplement of Ascorbic 
acid.  
2. “Juci” comes in the 
Problem Recognition: 
1. Is there any lacking of 
Ascorbic acid in the body? 
2. Does my family 
consume enough Ascorbic 
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Group 2. 
Group 3. 
Described below. 
flavor of orange.  
3. “Juci” enriches the 
immune system, helps 
with tissue growth and 
helps adrenal gland to 
function.   
4. First in it’s generic to 
come in juice form. 
5. Every sachet will 
contain 500mg of 
Ascorbic acid instead of 
250mg or 100mg. 
 
acid for their well-being? 
3. Am I taking necessary 
amount of Ascorbic acid 
to protect my immune 
system? 
4. Do I have enough 
Ascorbic acid in the body 
to have a normal tissue 
growth? 
5. Am I taking enough 
Ascorbic acid which will 
nourish the hair and skin? 
 
Competitors: 
Beximco, Square, 
Reneta, Bristol, 
Pharmadesh, 
Ambee, Incepta, 
Rephco, Globe, 
ACI, Popular, 
ACME, Navana. 
Group 1: 
People whom are 
suffering from lack 
of Ascorbic acid in 
the body. 
Price: 
10 MRP per Sachet 
200 MRP 20 Sachet/ box. 
Which is very much the 
same as other 
competitor’s product 
price margin. 
 
Information Search: 
1. Internet 
2. Physicians 
Conditions:  
1. Regulations 
from the drug 
commissions. 
2. Fixed price 
margin for the 
MRP value. 
Group 2: 
Literate and 
concerned people 
to understand the 
importance of 
physical benefits. 
Distribution: 
1. Everywhere in 
Bangladesh.  
2. Special attention: Lazz 
pharma, College get to 
shyamoli chemist shops, 
Chankharpul, 
ShahbagBirdem, Gulshan 
Market Chemist shops, 
Alternative Evaluation: 
1. Internet. 
2. Mobile awareness 
messages. 
3. Campaign. 
4. Physicians advise. 
5. Advice from friends, 
relatives, grown-ups, 
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Midford chemist shops. colleagues, family 
members. 
6. Chemist advice. 
7. Trying-out samples.  
 
Consumers: 
1. People whom 
are suffering 
from lack of 
Ascorbic acid in 
the body 
2.Health 
concerned 
people 
3. Consumers who 
are concerned 
about their skin 
and hair. 
Group 3: 
Consumers who 
are concerned 
about their skin 
and hair. 
Promotion: 
1. Mobile 
communication with the 
consumers. 
2. Various campaigns in 
various occasion. 
3. Free sample in front of 
schools, shopping places 
and university campus. 
Purchase: 
The purchase of the 
product will happen if the 
consumer comes to the 
decision that the benefits 
from the total product will 
out wage the cost of 
acquiring the benefits. 
Then we shall get the 
actual consumer value. 
  Service: 
Well packaged in green 
sachets which will be in a 
green colored family size 
box in case for the 
consumption of a larger 
group. 
 
Use and Evaluation: 
1. By not only using the 
product but also trying 
the samples and getting 
informed by the 
campaigns and mobile 
messages the consumer 
will get the idea about the 
product. 
2. The taste, color and 
essence of the product 
will create a memory in 
the consumer’s mind and 
will put a great impact in 
the next time he/she 
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purchases the same 
generic of the product for 
the same use.  
 
 
 
Applying the marketing strategies: 
 
Applying the marketing strategies we will dive into the micro level and analyze 
our target consumers, our proposition to them, differentiation from the 
competitors and our market segmentation. 
 
In the market there will be success and there will be failure, but to have the ability 
to control that we need to understand our competitors. We need to figure out, who 
they are? What do they do and what are the policies they are taking?  
 
Here applying the marketing principles we will get the knowledge of how our 
product will interact in the market. 
 
Of all the tactics of marketing strategy I have selected “Product Differentiation” 
technique and “Unique Selling Proposition” to create a very concrete image in the 
consumer‟s mind.  
 
Differentiation: 
 
The consumers should have a better reason to choose our product instead of the 
competitor‟s one. We will determine a difference between our product and the 
competitor‟s product. There is a notion that few will say that they are giving 
quality service, but this will work as a difference given that their competitors are 
giving zero quality assurance. Here we are the first to launch Ascorbic acid in 
juice form in the market of Bangladesh.   
 
 
Unique Selling Proposition: 
 
Of all the juices in the market ours are the best for health concerning issues. A 
very debating study in the market shows that few of the juices that are sold in the 
market has “artificial additive” in it. “Yellow Six” a very popular color additive 
has been used in many juices that are sold in Bangladesh. The FDA‟s website 
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proved to be a valuable database for food coloring information. Their site provides 
precisely what is in each of the colors and is quite disturbing. Yellow six has been 
banned by the FDA, but in many countries like ours it is not banned. So, for that 
many of the food and juice item in the market consist of it. As a matter of great 
concern yellow six contains lead and mercury metal which is really poisonous for 
human body. It also causes cancer. However our unique selling proposition is that 
our product does not contain yellow six.  
 
COMPETITORS’ PRODUCTS AND ANALYSIS: 
 
1. Price/ Product: 
There are many companies selling the same generic products, many are selling in tablets, some 
are selling in capsule, some are selling in juice form and last but not the least in injections, but a 
point that can be noted is that juice form is still not been introduced in the market. From the 
companies that are enlisted below few shows that they have an idea of the juice form they are 
going to sell, and because the information of the product is available we can assume that they at 
least have a marketing plan on it. 
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Brand Name  Company Name  Description Quantity Price 
Ascobex Beximco Ascorbic Acid 250mg/ Tablet 200s Pack 264 MRP 
Ascorin Bristol Ascorbic Acid 250 mg/ Tablet 200s Pack 164 MRP 
Ascoson Jayson Ascorbic Acid 100 mg/  5 ml 100 ml 33.22 MRP 
Ascoson Jayson Ascorbic Acid 250mg/ Tablet 200s Pack 282 MRP 
Ascovit Pharmadesh Ascorbic Acid 250mg/ Tablet 200s Pack 258 MRP 
Aspel SR Delta Pharma Ascorbic Acid BP 500mg/ Capsule 48s Pack 167.90 MRP 
C-Bon Ambee Ascorbic Acid 250mg/ Tablet 100s Pack 130 MRP 
C-gun Beximco Ascorbic Acid 125mg/ Tablet 30s Pack 113.70 MRP 
C-On Rephco Ascorbic Acid 250mg/ Sachet 10s Pack 50 MRP 
C-Vitera Millat Ascorbic Acid 250mg/ Tablet 1000s Pack 130 MRP 
Capcee SR Silva Ascorbic Acid BP 500mg/ Capsule 48s Pack 168 MRP 
Cecon Acme Ascorbic acid 250mg/ Tablet 100s Pack 131 MRP 
Ceegram 500 Incepta Ascorbic Acid BP & Sodium Ascorbate 
BP 500mg/ Tablet 
10s Pack 75 MRP 
Ceevit Square Ascorbic Acid 250mg/ Tablet 200s Pack 262 MRP 
Ceevit Forte Square Ascorbic Acid 1000mg/ Tablet 10s Pack 100 MRP 
Ceemet Medimet Ascorbic Acid 250mg/ Tablet 250s Pack 327.50 MRP 
Ceeta Syntho Ascorbic Acid 250mg/ Tablet 200s Pack 164 MRP 
Celin Glaxo Smith Kline Ascorbic Acid 250mg/ Tablet 200s Pack  262 MRP 
Cevalin Bio Pharma Ascorbic Acid 250mg/Tablet 200s Pack 262 MRP 
Cevion Health Care Ascorbic Acid 250mg/ Tablet 10s Pack 76.40 MRP 
Chewce Navana Ascorbic Acid 250mg/ Tablet 200s Pack 162 MRP 
Citavit Skylab Ascorbic Acid 250mg/ Tablet 200s Pack 162 MRP 
G-Vitamin-C Gonoshasthaya Ascorbic Acid 250mg/ Tablet 100s Pack  71 MRP 
Gevit Globe Ascorbic Acid 250mg/ Tablet 200s Pack 160 MRP 
Kvit- C Chemico Ascorbic Acid 250mg/ Tablet 50s Pack 40 MRP 
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Here, this is very visible that there is a price margin and all the products‟ MRP are the same with 
their respective quantity.  
 
 
 
Lemonic Gaco Ascorbic Acid 250mg/ Tablet 100s Pack 79.50 MRP 
Lemovit C Ziska Ascorbic Acid 250mg/ Tablet 200s Pack 262 MRP 
Mega-C Edruc Limited Ascorbic Acid 250mg/ Tablet 200s Pack 262 MRP 
Mega-C Edruc Limited Ascobic Acid BP 500mg/ 5ml ampoule/ 
injection 
10s Pack 50 MRP 
Nutrivit C ACI Ascorbic Acid 250mg/ Tablet 200s Pack  262.01 MRP 
Nutrivit C ACI Ascorbic Acid 100mg/ 5ml Syrup 100 ml 33.22 MRP 
Orange C APC Ascorbic Acid BP & Sodium Ascorbate 
BP 250mg/ Tablet 
200s Pack 164 MRP 
Rapid C Popular Ascorbic Acid 1000mg/ Tablet 9s Pack 90 MRP 
Rapid-C Popular Ascorbic Acid 100mg/ 5ml 100 ml 33.22 MRP 
Seema-C Seema Ascorbic Acid 250mg/ Tablet 200s Pack 262 MRP 
Suvic Amico Ascorbic Acid 250mg/ Tablet 200s Pack 150 MRP 
Vasco Opsonin Ascorbic Acid 250mg/ Tablet 200s Pack  262 MRP 
VC-205 Aristopharma Ascorbic Acid 250mg/ Tablet 200s Pack 260 MRP 
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2. Promotion: 
 
Given here is the top five companies‟ promotional activities on OTC product and the reason 
behind the product to be a threat. These companies have the most capability to respond using 
their financial resources and marketing strategies. At some point they might even start 
advertising their product with new and different BTL/ATL marketing strategies. 
 
Company Product Promotional Activity Reason for a Threat 
1. Square Ceevit, 
Ceevit Forte 
1. BTL marketing through 
the physicians and 
chemists  
2. Samples 
Goodwill in the market for a 
long time. 
2. Beximco Ascobex, C-
gun 
1. BTL marketing through 
physicians and chemists. 
2. Samples 
Brand is taking over so, there 
is the risk of the product 
taking over the market. 
3. Rephco C-On Product still not launched 
yet. 
Their product will come in the 
same form as our product on 
three different flavors. The 
product has not been 
launched but we may assume 
they are making a marketing 
plan on it has described by 
their product detail. 
4. Incepta Ceegram 
500 
BTL marketing through 
the physicians and 
chemists. 
Influential in facilitating the 
physicians 
5. Acme Cecon Facilitating physicians and 
medical practitioners. 
Influential in facilitating the 
physicians 
 
25 | P a g e  
 
PRICING & FORECAST: 
 
 
Pricing of the product is done bearing in mind two factors: Gross Profit and competitor‟s price.  
Considering the competitors price, the price of the product is not very different. Significantly 
higher or lower price than the competitors is highly uncommon in pharmaceutical industry. Only 
in case of some premium or originators products, price is set at a premium. Since „JUCI‟ is an 
OTC product, the straight pricing policy was operated to be set considering the generic price. 
The one contributing influences: COGS is the determining parameters here. The price while set 
identical to the opponents‟ price showed to generate nothing significant. Finished calculation of 
it was lastly obvious that the price will not be varied from that of the competitors. The finally 
obvious price of „JUCI‟ is as follows: 
 
 
 
Brand Name MRP/Pack TP/Pack 
JUCI 200 149.93 
 
PROFIT-LOSS ANALYSIS: 
 
 
 
Constructed on SK+F‟s internal standard, profit and loss analysis has been done. Previously our 
product was of 250mg per sachet but lower amount of production of the product brings out loss 
for the project. Now it has been determined to be marketed in 500mg more in quantity.  The 
organization‟s main cost in this project is the fixed operational cost. Even though the company is 
making a 25% profit on the gross margin, the high fixed operational cost is resulting in a loss per 
product. The only way to cover this loss is to increase the sales in subsequent years. As units of 
sales will increase, the total fixed cost will be distributed by a larger number of units and fixed 
cost per product will decrease resulting in some profitability for the product. 
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MARKETING PLAN FOR NEW PRODUCT LAUNCH: 
 
Since “Juci” is a new product and have not yet reached the market exposure, our 
plan will be to engage ourselves with the consumers, anticipating by creating 
awareness. Now we will see a chart concerning the Analysis of the variables that 
will put impact on the product characteristics, later we will see another chart on 
the analysis of the Target market. 
SELECTING TARGET CUNSUMER: 
 
We can understand that “Juci” is a product which mostly has more importance to 
the people who are concerned with their health. So, the question here would be 
which type of person would most likely be attracted to the product. The target 
market obviously has to be literate to understand the benefits of the product. Our 
target consumer will use our product because it takes less time to prepare a juice 
by simply pouring the mixture in a glass full of water than to go into a longer 
procedure to prepare the citrus food. Since it‟s a product which improves our 
immune system it will be preferable to the athletes and as it seems it ensures 
healthy hair and skin it will be also preferable to the young generation who are 
concerned about their complexion and beauty. Here is the list of our target 
consumers with the respective reasons. 
 
Target Consumers Reason 
1. Working Mother 1. The working mother is literate, 2. Concerned 
about her family and their well-being, 3. 
Would go and look for a product which can 
produce a quick outcome. 
2. University Students 1. University students are concerned young 
consumers, 2. Among them there will be 
athletes concerned about their stamina and 
physic, 3. Among them will be girls who are 
concerned about their hair and complexion. 
3. School and College 
Students. 
1. School and college students are a boat that 
will turn into a ship in the near future and will 
be a great area to exercise the product so that 
the image of the product can receive a 
common ground in the upcoming days as a 
general concern. 
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Geographic: 
 Sylhet   
 Chittagong  
 Dhaka  
 Rajshahi 
 Khulna &Barishal. 
 
Demographics: 
 Consumers  
 Weak, proactive, guardians (High potential)  
 Status driven, sensitive, trend friendly (High potential)  
 Health conscious, serum friendly (High potential)  
 Contemporary, informed, confident women (High potential)  
 Traditional motherly (Low potential)  
 Family-oriented, not self-oriented (Low potential)  
 Simple, practical pessimists (Low potential)  
 Independent, living for the moment (Low potential)  
 Uninformed and unconcerned  (Low potential) 
 
Physicians are kept in the list to make minor influence on their patients. 
Surely a medic will write the vitamins at the last line of the prescription which 
will not make huge importance concerning an average person.    
 
Physicians.  
 Passive conservatives  
 Optimists  
 New students  
 Proactive revolutionary    
 
Patients. 
 Dependent child/ woman on parents (High priority)  
 Adult women who are “investing in their future” (High priority)  
 
Psychographics 
 Higher class  
 Middle class (most priority)  
 Lower class (the next area of concern) 
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INTERACTION IN THE MARKET: 
 
 
 
 
Our targeted consumers will go through the upper process. First he/she is going to 
search information to buy the product. Secondly, they are going to judge one of 
the brand based on the information searched. When they will see our product has a 
superior value considering the USP and the product differentiation, they will buy 
our product. After that sales will occur and then using the product the consumer 
will realize the perceived value and gain consumer satisfaction. From then on the 
consumer will again choose our product because it made a memory in the 
consumers mind.  
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Then the consumer will share information about his/her experience with the 
product. Conscious mothers will share the information with their co-workers, 
hometown friends and immediate family. Athletes will share their information 
with their team members and students will share with their classmates from 
school, university and college.  
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SWOT ANALYSIS: 
 
 
Strength: 
 
“Juci” is a product of reputed company SK+F which is doing business under 
Transcom group for many years in Bangladesh. As SK+F is already holding a 
position in the consumer‟s mind, a new product penetration will be easy as the 
distribution channel of Transcom, TDCL will be managing the product to reach 
the consumers hand. 
 
Weakness: 
 
Since this is a product under OTC category, many other companies can come up 
with the same product category. However we have seen that the price will not 
differ from the competitors, so pricing strategy will not be an effective area to 
work on.  
 
 
Opportunities: 
 
The opportunity of the product over here is that the form of the product is new in 
the market. There are no other companies selling the same product in juice from. 
So, we have the upper hand to set a brand position of this product on juice form 
with no other competitors taking the primary stage in the consumer perception. 
 
Threat: 
 
Keeping in mind any threat of new entrants, there is a high possibility that usually 
consumers going to the physicians will not provide importance to the product if it 
is prescribed with many other important drugs. They will probably ignore the 
product if it is written in the last line of the prescription. However there is a big 
question. If the competitors come up with a strategy robust enough to withstand 
the activity of ours with the same form of product? 
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MY PROPOSAL ON PROMOTIONAL ACTIVITIES: 
 
Promotional activities are different concerning the area of product. Over here our 
product is an OTC product so we shall have to exclude traditional promotional 
techniques. We made a promotional mix based on the product category 
concerning the target consumers.   
 
Promotional Mix: 
 
Here is the ‟Promotional mix‟ influenced mostly by BTL marketing. This is a set 
of tools that we can use to communicate effectively on the benefits of its products 
or services to its customers. The promotional mix includes the following tools.  
• Free sampling  
• Supply of promotional gifts related to the product   
• Sales promotion to doctors  
• Creating concerns through agents.  
 
 
1. Free sampling: 
 
 
We will provide free samples to one of our target consumer group. This consumer 
group contains school, college and university students.  
 
For schools and colleges we will rent few pickups and hire two person to operate 
the activity. Then we are going to send them in front of the schools and colleges. 
There they will give them one free juice with one T-shirt and one of the operator 
will take feedback from the consumers. The t-shirt on the other hand will have our 
product logo. This will be very good in the sense of getting exposure immediately 
since summer is coming. 
 
For universities, we will make stalls in the cafeteria and provide free sample of 
our product for one day in every university in Bangladesh. We will need two 
person to operate that, one will provide the juice in a glass and another one will be 
taking feedbacks. 
 
32 | P a g e  
 
This way we will make consumer under the age of 25 aware about our product. 
All feedbacks will be analyzed to figure out the coming development of the 
product, but this analysis will take longer period as the data list is huge. 
2. Supply of promotional gifts related to theproduct: 
 
We will supply mugs, diaries and calendars to the doctors, the chemists and the 
young medical students. All the materials over here will have our product stickers. 
Through them other people will get to know of the product. Why mugs on the first 
place? Because our product is a thing to drink, every time someone‟s drinking 
something with our mug he/she will subconsciously will think about „Juci‟. Next 
time this he/she might also buy the product just because he/she remembered that 
he/she has a glass of the same product sticker. 
 
3. Sales promotion to Physicians: 
 
We will ask the doctors to not to write it in the prescription rather hang a calendar 
or poster of our product behind them and to point at it when preferring Juci to the 
patients. This way the consumers of this criteria will pay extra attention to the 
product. The type of doctors we want to keep in hand are given below.   
 
 Passive conservatives:This kind of doctors are very easy to pursue. They 
always want to taste better things. We can facilitate them with a tablet pc 
or an android for them to activate themselves in the so called social 
network. 
 
 Optimists:Optimistic doctors are good listeners and they are ready to hear 
anything that make sense. We just have to talk to some optimistic doctors 
to get the ideas of our product flowing in the selection of logical products 
list. 
 
 New students:New medical students are very new in the field, so there is 
a higher probability that their mentality can be manipulated easily. We 
will start listing the most loyal doctors in the field from a very earlier stage 
of their career. 
 
 Proactive revolutionary:Lesser spending on promotion increases the 
ultimate profit. Now, over here we will try to rationalize our product with 
the doctors who think of them as a revolutionary figure, saving life, 
playing god etc.As they think automatically in a righteous way, we just 
have to push our product into the righteous part of his/her brain. 
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4. Creating concerns through agents: 
 
In every university, football team and social gathering there will be this one 
guy/girl who will attract people and make them listen to him or her. To most 
people they are like the most logical human being living and has answers to all the 
questions. This kind of ability now a days is not a special one. Good reactive 
skills achievers are the one who can make a huge impact by channeling 
information in front of few audience. He/she will not accidently start talking about 
our product instead will talk about it channeling through information from a 
different topic. I would like to call them the RMA “Reactive Magnet Agents”. We 
will select this kind of personality when we will go for the promotion with the 
free samples. The guy who will take the feedbacks from the two will observe such 
personalities. Then will call and manage them to talk about our product in the 
social gatherings and for that we will compensate them. 
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Conclusion 
 
 
 
 
Bangladesh pharmaceutical market is growing in a remarkable rate. In Six years (from 2010 to 
2015) the scope of the market nearly doubled. Rivalry is aggressive in the market, but there is a 
growth potential in the market. Eskayef Bangladesh Limited is no exclusion. Sideways with 
other plans like bringing up their own studied product to Bangladesh market, they are also 
demanding to win greater share of the generic market. Deciding to launch the pellets portfolio is 
one large step in attaining a better position in the generic drug market.  
 
It is such a multifaceted job that for every marketer in the pharmaceutical segment it is a 
stimulating experience as pharmaceutical marketing is an important task and the product 
launching is even more. The interdepartmental environment of the jobs makes it enormously 
collaborative. The product manager has to manage this many stake holders that he has to be very 
cautious about upholding the equilibrium.  
 
Beginning from the early market investigation and profit-loss analysis, thorough particular and 
impartial decision making capabilities are mandatory. Meeting the target is always significant 
but it needs extra effort in case of product launching. A well-organized communication track has 
to be continued among the retrograde stakeholders (supply chain & production) to the 
accelerative stakeholders (distribution & sales). Also the task of handling external stakeholders, 
is involved in many steps of launching.  
 
The liability of initiating a new OTC product is serious in the intellect that, for the business, it is 
a phase onward to capitalize growth opportunities. Introduction of a new product is also an acute 
involvement for a product manager. It necessitates collaboration with almost every division of a 
pharmaceutical company. This is possibly the finest technique of receiving an in depth 
understanding of the pharmaceutical marketing job. Presence in the product launch procedure at 
Eskayef Bangladesh Limited was an inspiring involvement. 
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